CareDx, Inc (CDNA)
USD 20.4
(-7.86%)
USD 20.4
(-7.86%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 277.76 Million USD | -3.15% |
| 2022 | 286.81 Million USD | 25.39% |
| 2021 | 228.73 Million USD | 55.82% |
| 2020 | 146.79 Million USD | 38.29% |
| 2019 | 106.14 Million USD | 82.56% |
| 2018 | 58.14 Million USD | 31.82% |
| 2017 | 44.1 Million USD | -0.38% |
| 2016 | 44.27 Million USD | 47.94% |
| 2015 | 29.92 Million USD | 59.59% |
| 2014 | 18.75 Million USD | 35.14% |
| 2013 | 13.87 Million USD | -6.63% |
| 2012 | 14.86 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q3 | 93.37 Million USD | -2.85% |
| 2024 Q2 | 67.73 Million USD | 4.49% |
| 2024 Q1 | 64.81 Million USD | 2.6% |
| 2023 Q1 | 75.62 Million USD | 5.01% |
| 2023 Q2 | 71.19 Million USD | -5.86% |
| 2023 Q4 | 63.17 Million USD | -11.57% |
| 2023 Q3 | 71.44 Million USD | 0.35% |
| 2023 FY | 277.76 Million USD | -3.15% |
| 2022 Q4 | 72.01 Million USD | 5.29% |
| 2022 FY | 286.81 Million USD | 25.39% |
| 2022 Q1 | 71.58 Million USD | 5.87% |
| 2022 Q2 | 74.81 Million USD | 4.51% |
| 2022 Q3 | 68.39 Million USD | -8.58% |
| 2021 FY | 228.73 Million USD | 55.82% |
| 2021 Q1 | 46.67 Million USD | 9.0% |
| 2021 Q4 | 67.61 Million USD | 13.68% |
| 2021 Q3 | 59.48 Million USD | 8.23% |
| 2021 Q2 | 54.95 Million USD | 17.73% |
| 2020 Q2 | 32.76 Million USD | 3.24% |
| 2020 FY | 146.79 Million USD | 38.29% |
| 2020 Q1 | 31.73 Million USD | 10.78% |
| 2020 Q4 | 42.82 Million USD | 8.53% |
| 2020 Q3 | 39.46 Million USD | 20.43% |
| 2019 Q4 | 28.65 Million USD | -1.42% |
| 2019 Q2 | 26.78 Million USD | 23.75% |
| 2019 FY | 106.14 Million USD | 82.56% |
| 2019 Q1 | 21.64 Million USD | 40.42% |
| 2019 Q3 | 29.06 Million USD | 8.5% |
| 2018 Q4 | 15.41 Million USD | 2.66% |
| 2018 FY | 58.14 Million USD | 31.82% |
| 2018 Q3 | 15.01 Million USD | 0.43% |
| 2018 Q2 | 14.95 Million USD | 17.18% |
| 2018 Q1 | 12.76 Million USD | 23.52% |
| 2017 Q1 | 13 Million USD | 26.89% |
| 2017 FY | 44.1 Million USD | -0.38% |
| 2017 Q4 | 10.33 Million USD | 0.76% |
| 2017 Q3 | 10.25 Million USD | -2.55% |
| 2017 Q2 | 10.52 Million USD | -19.12% |
| 2016 Q2 | 11.8 Million USD | 11.66% |
| 2016 Q1 | 10.57 Million USD | 27.47% |
| 2016 FY | 44.27 Million USD | 47.94% |
| 2016 Q3 | 11.56 Million USD | -2.07% |
| 2016 Q4 | 10.25 Million USD | -11.33% |
| 2015 Q1 | 6.14 Million USD | 16.41% |
| 2015 FY | 29.92 Million USD | 59.59% |
| 2015 Q4 | 8.29 Million USD | 2.13% |
| 2015 Q3 | 8.12 Million USD | 10.26% |
| 2015 Q2 | 7.36 Million USD | 19.78% |
| 2014 FY | 18.75 Million USD | 35.14% |
| 2014 Q2 | 4.71 Million USD | 18.28% |
| 2014 Q4 | 5.28 Million USD | 10.85% |
| 2014 Q3 | 4.76 Million USD | 1.0% |
| 2014 Q1 | 3.98 Million USD | 32.39% |
| 2013 Q3 | 3.63 Million USD | 1.14% |
| 2013 Q1 | 3.63 Million USD | 0.0% |
| 2013 FY | 13.87 Million USD | -6.63% |
| 2013 Q2 | 3.59 Million USD | -1.13% |
| 2013 Q4 | 3.01 Million USD | -17.11% |
| 2012 FY | 14.86 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Bionano Genomics, Inc. | 148.99 Million USD | -86.43% |
| Prenetics Global Limited | 60.73 Million USD | -357.332% |
| Star Equity Holdings, Inc. | 16.27 Million USD | -1607.03% |
| Exact Sciences Corporation | 2.06 Billion USD | 86.52% |
| Exagen Inc. | 52.29 Million USD | -431.176% |
| Inotiv, Inc. | 246.9 Million USD | -12.501% |
| Guardant Health, Inc. | 901.62 Million USD | 69.192% |
| Biodesix, Inc. | 77.41 Million USD | -258.785% |
| BioNexus Gene Lab Corp. | 3.92 Million USD | -6980.344% |
| Precipio, Inc. | 13.63 Million USD | -1936.721% |
| iSpecimen Inc. | 16.27 Million USD | -1606.478% |
| Natera, Inc. | 938.98 Million USD | 70.418% |
| Aspira Women's Health Inc. | 24.11 Million USD | -1051.895% |
| Standard BioTools Inc. | 113.48 Million USD | -144.753% |
| 23andMe Holding Co. | 420.73 Million USD | 33.98% |
| Castle Biosciences, Inc. | 242.78 Million USD | -14.41% |
| Personalis, Inc. | 128.14 Million USD | -116.762% |
| Aclaris Therapeutics, Inc. | 110.52 Million USD | -151.317% |
| Applied DNA Sciences, Inc. | 16.48 Million USD | -1584.798% |
| OpGen, Inc. | 30.65 Million USD | -806.022% |
| T2 Biosystems, Inc. | 41.49 Million USD | -569.417% |
| Myriad Genetics, Inc. | 600.1 Million USD | 53.713% |
| ICON Public Limited Company | 755.64 Million USD | 63.241% |
| NeoGenomics, Inc. | 341.25 Million USD | 18.603% |
| Star Equity Holdings, Inc. | 16.27 Million USD | -1607.03% |
| IDEXX Laboratories, Inc. | 1.09 Billion USD | 74.583% |
| RadNet, Inc. | 268.87 Million USD | -3.306% |
| MDxHealth SA | 71.25 Million USD | -289.817% |
| Psychemedics Corporation | 11.33 Million USD | -2350.75% |
| Illumina, Inc. | 3.81 Billion USD | 92.715% |
| Check-Cap Ltd. | 19.28 Million USD | -1340.183% |
| Twist Bioscience Corporation | 354.18 Million USD | 21.574% |
| DarioHealth Corp. | 62.17 Million USD | -346.766% |
| Fulgent Genetics, Inc. | 171.9 Million USD | -61.581% |
| Sera Prognostics, Inc. | 39.91 Million USD | -595.864% |
| ENDRA Life Sciences Inc. | 10.52 Million USD | -2540.196% |
| OPKO Health, Inc. | 574.68 Million USD | 51.666% |
| Medpace Holdings, Inc. | 187.68 Million USD | -48.001% |
| Neogen Corporation | 405.23 Million USD | 31.455% |
| Intelligent Bio Solutions Inc. | 11.7 Million USD | -2272.301% |
| Prenetics Global Limited | 60.73 Million USD | -357.332% |
| Mainz Biomed B.V. | 27.15 Million USD | -922.923% |
| bioAffinity Technologies, Inc. | 8.76 Million USD | -3069.116% |
| Trinity Biotech plc | 46.49 Million USD | -497.415% |
| Neuronetics, Inc. | 82.25 Million USD | -237.675% |
| Sotera Health Company | 300.46 Million USD | 7.554% |
| bioAffinity Technologies, Inc. | 8.76 Million USD | -3069.116% |